The Association of Gross Tumor Volume and Its Radiomics Features with Brain Metastases Development in Patients with Radically Treated Stage III Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Around 30% of patients with stage III non-small cell lung cancer (NSCLC) receiving radical chemoradiotherapy will develop symptomatic brain metastases (BM) during the disease course. Identifying risk factors for BM can help improve the management of these patients. The aim of this cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Haiyan, Tohidinezhad, Fariba, De Ruysscher, Dirk K. M., Willems, Yves C. P., Degens, Juliette H. R. J., van Kampen-van den Boogaart, Vivian E. M., Pitz, Cordula, Cortiula, Francesco, Brandts, Lloyd, Hendriks, Lizza E. L., Traverso, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252119/
https://www.ncbi.nlm.nih.gov/pubmed/37296973
http://dx.doi.org/10.3390/cancers15113010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252119/
https://www.ncbi.nlm.nih.gov/pubmed/37296973
http://dx.doi.org/10.3390/cancers15113010

Ejemplares similares